Medicinal cannabis products that meet the minimum quality standard
10 May 2023: New medicinal cannabis products have been verified as meeting the minimum quality standard – Read more.
Generally, medicinal cannabis products are only available, on prescription, if they have:
- been assessed by the Medicinal Cannabis Agency as meeting the minimum quality standard under the Misuse of Drugs (Medicinal Cannabis) Regulations 2019, or
- obtained consent for distribution under the Medicines Act 1981 (approved and provisionally approved medicines)
Any doctor can prescribe a product listed here. A specialist recommendation and Ministerial approval are not required. For more information on a particular product, please contact the listed product supplier or manufacturer.
Medicinal cannabis products that meet the minimum quality standard under the Misuse of Drugs (Medicinal Cannabis) Regulations 2019
The minimum quality standard is used to verify medicinal cannabis products which have been derived from the Cannabis plant. Synthetic CBD and THC products are unable to be verified to meet the minimum quality standard as they are not derived from the Cannabis plant.
Products that are listed as having been verified as meeting the minimum quality standards are unapproved medicines – there has been no assessment of their safety or efficacy. Being listed here does not guarantee that these products are currently available in New Zealand. Contact the licence holder to obtain the most up-to-date information on product availability.
Dosage Products – Prescription Medicine
The products listed in the following tables are categorised by their verified dosage form. The products have been verified as meeting the testing requirements and microbiological contamination limits applicable to the dosage form as listed.
Oral Liquids
Product Name | Active Ingredients | Pack Sizes (mL) | Administration notes | Licence holder |
---|---|---|---|---|
Helius CBD25 Full Spectrum | Total CBD (CBD+CBDA) 25 mg/mL | 30 | Oral, withdraw prescribed dose using provided dropper and dispense into mouth | Helius Therapeutics Limited |
Helius CBD100 Full Spectrum | Total CBD (CBD+CBDA) 100 mg/mL | 30 | Oral, withdraw prescribed dose using provided dropper and dispense into mouth | Helius Therapeutics Limited |
RUA CBD100 | Total CBD (CBD+CBDA) 100 mg/mL | 30 | Oral, 1mL oral syringe with 0.05 mL volume markings | RUA Bioscience Limited |
Tilray P Oral Solution CBD 100 | Total CBD (CBD+CBDA) 106.4 mg/g (100 mg/mL) | 25, 40 | Oral, 1 mL oral syringe with 0.1 mL volume markings | CDC Pharmaceuticals Ltd |
Tilray P Oral Solution CBD 25 | Total CBD (CBD+CBDA) 26.6 mg/g (25 mg/mL) | 40 | Oral, 1 mL oral syringe with 0.1mL volume markings | CDC Pharmaceuticals Ltd |